Sartorius Pref Shs
Stock
Stock
ISIN: DE0007165631
Ticker: SRT3
DE0007165631
SRT3
Price
Price
CHART BY
Frequently asked questions
What is Sartorius Pref Shs's market capitalization?
The market capitalization of Sartorius Pref Shs is $21.19B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Sartorius Pref Shs's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Sartorius Pref Shs is 87.78. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Sartorius Pref Shs?
Sartorius Pref Shs's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.496. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Sartorius Pref Shs's stock?
Currently, 23 analysts cover Sartorius Pref Shs's stock, with a consensus target price of $330.88. Analyst ratings provide insights into the stock's expected performance.
What is Sartorius Pref Shs's revenue over the trailing twelve months?
Over the trailing twelve months, Sartorius Pref Shs reported a revenue of $4.11B.
How many employees does Sartorius Pref Shs have, and what sector and industry does it belong to?
Sartorius Pref Shs employs approximately 14,042 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Sartorius Pref Shs's shares?
The free float of Sartorius Pref Shs is 23.46M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $21.19B
- EPS (TTM)
- $3.496
- Free Float
- 23.46M
- P/E ratio (TTM)
- 87.78
- Revenue (TTM)
- $4.11B
Pricing
- 1D span
- $304.24$316.73
- 52W span
- $230.54$317.43
Analyst Ratings
The price target is $330.88 and the stock is covered by 23 analysts.
Buy
19
Hold
3
Sell
1
Information
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through the Bioprocess Solutions (BPS) and Lab Products and Service (LPS) segment. The BPS segment focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The LPS segment serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
- Employees
- 14,042
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- DE0007165631
- Primary Ticker
- SRT3
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet